In order to explore the relationship between ALOX5, FLAP, ALOX12 and ALOX15 polymorphisms and CRC risk, a U.S. cohort analysis found that genetic variants in ALOXs may affect the risk of colorectal tumor development and alter the protective effect of NSAID use on CRC 98. The gene discussed is ALOX5; the disease is colorectal carcinoma.